Analyst Price Targets — GAIN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 4, 2026 1:35 pm | — | Oppenheimer | $15.00 | $14.29 | TheFly | Gladstone Investment price target raised to $15 from $14 at Oppenheimer |
Latest News for GAIN
Morgan Stanley Direct Lending Fund (NYSE: MSDL - Get Free Report) and Gladstone Investment (NASDAQ: GAIN - Get Free Report) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends. Dividends Morgan Stanley Direct
Gladstone Investment has issued a new exchange-traded debt security: 7.125% Notes due 2031. GAIN's asset coverage ratio remains robust, projected between 189% and 201% post-issuance, well above the 150% regulatory minimum. GAING is fairly priced relative to GAIN's existing notes and BDC sector peers.
Gladstone Investment offers a base dividend yield of 7% with potential for supplemental payouts as SaaSpocalypse-driven volatility hits BDC returns. GAIN's dividend coverage dipped to 88% in the latest quarter, but a strong dividend history partially supports confidence amid broader BDC dividend cuts. Net asset value per share rose to $14.95, driven by $70.2 million in net unrealized appreciation, offsetting…
Preferreds/Bond Weekly Review: Issuers Are Jumping Into The Market
Gladstone Investment: Efficient Portfolio Strategy Leads To NAV Growth
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GAIN.
U.S. House Trading
No House trades found for GAIN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.